Citizens (CIA) Stock: Buy, Sell, or Hold?
CIA - Citizens, Inc.
$3.58
0.08 (2.29%)
▲
5d:
-9.82%
30d:
-8.67%
90d:
-34.91%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When CIA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CIA shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CIA shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$6.39
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$3.97
9.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CIA is currently trading at $3.58, which is considered oversold relative to its 30-day fair value range of $3.64 to $4.18. The stock's valuation (Forward PE: 17.9) is in line with its historical norms (16.4). At these levels, the market is pricing in 2.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CIA is in a strong downtrend. Immediate support is located at $3.46, while resistance sits at $4.05.
Market Sentiment: CIA scores 17/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.25 (+46.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CIA is in a strong downtrend. Immediate support is located at $3.46, while resistance sits at $4.05.
Market Sentiment: CIA scores 17/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.25 (+46.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.64 -
$4.18
Company Quality Score
30/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
58.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (17/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 46.6% below Wall St target ($5.25)
- NEUTRAL: Market pricing in 2.9% annual earnings growth - fairly valued
- WARNING: Composite score 30/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.64 -
$4.18
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.46
Resistance Level
$4.06
Current Trend
Strong Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.90
Wall Street Target
$5.25
(+46.6%)
Revenue Growth (YoY)
-7.2%
Earnings Growth (YoY)
99.5%
Profit Margin
4.5%
Valuation Premium vs History
+2.9% premium
PE vs Historical
17.9 vs 16.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.9%
(market-implied from PE analysis)
1-Year Target
$3.68
(+3%)
2-Year Target
$3.79
(+6%)
3-Year Target
$3.90
(+9%)
3-Yr Target (if PE normalizes)
(PE: 18→16)
PE COMPRESSION
$3.57
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 66.7%)
$13.61
(+280%)
Base:
(SPY PE: 17.9, Growth: 66.7%)
$12.08
(+238%)
Bear:
(PE: 15.2, Growth: 66.7%)
$10.27
(+187%)
📈
Valuation based on Current Earnings
Trailing PE: 16.67 | Current EPS (TTM): $0.21
Bull Case
$3.67
(+2%)
Analyst growth -4.8%, PE expands to 18.3
Base Case
$3.33
(-7%)
Market implied -4.8%, PE stable at 16.7
Bear Case
$2.38
(-34%)
Severe decline -20.0%, PE contracts to 14.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: September 12, 2026 10:55 AM ET
Data refreshes hourly during market hours. Next update: 11:55 AM
Data refreshes hourly during market hours. Next update: 11:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CIA showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Cynthia H Davis
BUY
100 shares
2026-03-25
Jon Stenberg
BUY
10000 shares
2026-03-17
Top Rated Insurance - Life Stocks
Top-rated stocks in Insurance - Life by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MET
MetLife Inc |
STRONG BUY
16 analysts |
$105 | 50 HOLD |
|
UNM
Unum Group |
BUY
13 analysts |
$102 | 42 HOLD |
|
MFC
Manulife Financial Corp |
BUY
13 analysts |
$35 | 49 HOLD |
|
GL
Globe Life Inc |
BUY
10 analysts |
$194 | 61 BUY |
|
ABL
Abacus Life Inc. |
STRONG BUY
5 analysts |
$14 | 42 HOLD |
